CuraScientific Corp (CSTF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CuraScientific Corp (CSTF) with AI Score 42/100 (Weak). CuraScientific Corp. manufactures and distributes cannabis, cannabidiol, kava, and kratom products under the JW Brands and Chad Enterprises brands. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 15, 2026CuraScientific Corp (CSTF) Healthcare & Pipeline Overview
CuraScientific Corp. (CSTF) is a manufacturer and distributor of cannabis, cannabidiol, kava, and kratom products, operating under the JW Brands and Chad Enterprises brands. Formerly Boon Industries, the company focuses on the specialty and generic drug market, based in Coachella, California.
Investment Thesis
Investing in CuraScientific Corp. (CSTF) presents a high-risk, high-reward scenario. The company's negative profit margin of -15299.2% and gross margin of -3298.1% indicate significant financial challenges. Growth catalysts include potential expansion of its product line and market reach within the cannabis and nutraceutical sectors. However, the company's small size (2 employees) and OTC market listing introduce substantial risks related to liquidity and regulatory compliance. The negative beta of -4.74 suggests an inverse correlation with the market, which could be a factor during market downturns. Investors should carefully consider the speculative nature of this investment, given the company's current financial performance and operational scale.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E ratio of -0.00 reflects the company's current lack of profitability.
- Profit margin of -15299.2% highlights significant operational inefficiencies and cost management issues.
- Gross margin of -3298.1% suggests that the company's cost of goods sold far exceeds its revenue, indicating fundamental problems with its business model.
- Beta of -4.74 indicates an inverse correlation with the market, which could offer diversification benefits but also reflects the company's unique risk profile.
Competitors & Peers
Strengths
- Established brands (JW Brands and Chad Enterprises).
- Diverse product offerings (cannabis, CBD, kava, kratom).
- Early mover advantage in emerging markets.
Weaknesses
- Limited financial resources.
- Small operational scale (2 employees).
- Negative profit and gross margins.
- OTC market listing.
Catalysts
- Upcoming: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.
- Ongoing: Increasing consumer demand for cannabis and related products is driving market growth.
- Ongoing: Expansion of the company's product line and distribution network could lead to increased revenue.
Risks
- Potential: Intense competition from larger and more established companies.
- Potential: Evolving regulatory landscape could create compliance challenges and increase costs.
- Ongoing: Limited financial resources and small operational scale could hinder growth.
- Ongoing: Negative profit and gross margins raise concerns about the company's financial sustainability.
- Ongoing: OTC market listing introduces risks related to liquidity and transparency.
Growth Opportunities
- Expansion into New Product Lines: CuraScientific Corp. can explore developing and launching new cannabis-related products, such as edibles, concentrates, and topicals, to cater to a broader customer base. The global cannabis market is projected to reach $90.4 billion by 2026, presenting significant revenue opportunities. This expansion requires investment in research and development, as well as compliance with regulatory standards. Timeline: 12-24 months.
- Geographic Market Expansion: The company can expand its distribution network to new states and regions where cannabis is legal, increasing its market reach and revenue potential. The U.S. cannabis market alone is expected to reach $43 billion by 2025. This expansion requires navigating varying state regulations and establishing partnerships with local distributors. Timeline: 18-36 months.
- Strategic Partnerships and Acquisitions: CuraScientific Corp. can pursue strategic partnerships or acquisitions to enhance its product portfolio, expand its market access, and gain economies of scale. The fragmented cannabis market offers opportunities for consolidation. This strategy requires careful due diligence and integration planning. Timeline: 24-48 months.
- Development of Proprietary Formulations: Investing in research and development to create proprietary cannabis formulations with unique health benefits can provide a competitive advantage and attract a loyal customer base. The market for innovative cannabis products is growing rapidly. This requires investment in scientific research and intellectual property protection. Timeline: 36-60 months.
- Focus on E-commerce and Direct-to-Consumer Sales: Establishing a strong online presence and direct-to-consumer sales channel can improve margins and enhance customer engagement. The e-commerce market for cannabis products is expanding rapidly. This requires investment in website development, digital marketing, and logistics infrastructure. Timeline: 12-24 months.
Opportunities
- Expansion into new product lines.
- Geographic market expansion.
- Strategic partnerships and acquisitions.
- Development of proprietary formulations.
Threats
- Intense competition.
- Evolving regulatory landscape.
- Changing consumer preferences.
- Limited access to capital.
Competitive Advantages
- Brand recognition through JW Brands and Chad Enterprises (limited evidence of brand strength).
- Proprietary formulations (if any).
- Distribution network (limited information available).
About CSTF
CuraScientific Corp., formerly known as Boon Industries, was incorporated in 2020 and rebranded in April 2023. The company is involved in the manufacturing, distribution, and sale of cannabis products, cannabidiol (CBD), kava, and kratom. These products are marketed under the JW Brands and Chad Enterprises brand names. Based in Coachella, California, CuraScientific Corp. operates within the specialty and generic drug manufacturing industry. The company's business model focuses on catering to the growing market for alternative wellness products. It aims to establish a presence in the competitive cannabis and related products market through its branded offerings. CuraScientific Corp. faces the challenges of navigating the complex regulatory landscape and intense competition within the cannabis and nutraceutical sectors. The company's success will depend on its ability to effectively market its products, maintain quality control, and adapt to changing consumer preferences and regulatory requirements.
What They Do
- Manufactures cannabis products.
- Distributes cannabis products.
- Sells cannabis products under the JW Brands brand.
- Sells cannabis products under the Chad Enterprises brand.
- Offers cannabidiol (CBD) products.
- Offers kava products.
- Offers kratom products.
Business Model
- Manufactures cannabis, CBD, kava, and kratom products.
- Distributes products through various channels.
- Generates revenue through the sale of branded products.
Industry Context
CuraScientific Corp. operates in the Drug Manufacturers - Specialty & Generic industry, which is experiencing growth driven by increasing demand for cannabis and related products. The market is characterized by intense competition and evolving regulatory landscapes. Companies like GRVE and CNNXF are also active in this space. CuraScientific Corp. faces the challenge of differentiating itself and establishing a sustainable market position. The industry is subject to changing consumer preferences and regulatory requirements, requiring companies to be agile and innovative.
Key Customers
- Consumers seeking cannabis products.
- Consumers seeking cannabidiol (CBD) products.
- Consumers seeking kava products.
- Consumers seeking kratom products.
Financials
Chart & Info
CuraScientific Corp (CSTF) stock price: Price data unavailable
Latest News
No recent news available for CSTF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CSTF.
Price Targets
Wall Street price target analysis for CSTF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CSTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Samuel L. Berry
Managing Employee
Samuel L. Berry is currently the managing employee of CuraScientific Corp. His background and experience prior to joining CuraScientific Corp. are not detailed in the provided data. As the managing employee, he is responsible for overseeing the company's operations and strategy.
Track Record: Due to the limited information available, it is not possible to assess Samuel L. Berry's track record at CuraScientific Corp. or any previous roles. The company's performance metrics, such as negative profit and gross margins, suggest significant challenges during his tenure.
CSTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that CuraScientific Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and higher price volatility compared to those listed on major exchanges like NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Higher price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with the OTC market.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal disputes.
- Company has a registered business address.
- Company has a website and contact information.
- Company has been in operation since 2020.
- Company rebranded in April 2023, indicating ongoing operations.
- Company offers specific products (cannabis, CBD, kava, kratom).
Common Questions About CSTF
What does CuraScientific Corp do?
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis, cannabidiol (CBD), kava, and kratom products. These products are marketed under the JW Brands and Chad Enterprises brand names. The company operates within the specialty and generic drug manufacturing industry, focusing on catering to the growing market for alternative wellness products. CuraScientific Corp. faces the challenges of navigating the complex regulatory landscape and intense competition within the cannabis and nutraceutical sectors.
What do analysts say about CSTF stock?
There is no available analyst coverage for CuraScientific Corp. (CSTF) due to its OTC listing and small market capitalization. Key valuation metrics, such as P/E ratio and profit margin, are negative, reflecting the company's current financial challenges. Growth considerations include potential expansion into new product lines and geographic markets, but these are subject to significant risks and uncertainties. Investors should conduct their own thorough due diligence before considering an investment in CSTF.
What are the main risks for CSTF?
The main risks for CuraScientific Corp. (CSTF) include intense competition, evolving regulatory landscape, limited financial resources, negative profit and gross margins, and its OTC market listing. The company's small operational scale and lack of financial disclosure raise concerns about its sustainability. Investors should be aware of the potential for illiquidity and price volatility associated with OTC stocks. The company's ability to navigate these risks will determine its long-term success.
What are the key factors to evaluate for CSTF?
CuraScientific Corp (CSTF) currently holds an AI score of 42/100, indicating low score. Key strength: Established brands (JW Brands and Chad Enterprises).. Primary risk to monitor: Potential: Intense competition from larger and more established companies.. This is not financial advice.
How frequently does CSTF data refresh on this page?
CSTF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CSTF's recent stock price performance?
Recent price movement in CuraScientific Corp (CSTF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands (JW Brands and Chad Enterprises).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CSTF overvalued or undervalued right now?
Determining whether CuraScientific Corp (CSTF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CSTF?
Before investing in CuraScientific Corp (CSTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market listing introduces additional risks and uncertainties.
- AI analysis pending for CSTF.